HOME >> BIOLOGY >> NEWS
High-pressure Oxygen Therapy Could Offer Widespread Benefits

WASHINGTON, D.C. -- Hyperbaric oxygen therapy offers enough promise for treating victims of stroke and other debilitating traumas and diseases of the central nervous system to warrant in-depth scientific studies, a medical researcher said today.

Speaking at a meeting of the Space and Underwater Research Group of the World Federation of Neurology, Dr. Stephen Thom said that doctors do not have a clear understanding of why hyperbaric oxygen therapy works. Nonetheless, small-scale studies indicate that it may be useful, he said.

The meeting is being coordinated by the Stroke Research Center of the Wake Forest University Baptist Medical Center.

Hyperbaric oxygen therapy, or HBOT, refers to the practice of putting patients in pressure chambers and having them breathe pure oxygen at two or more times normal atmospheric pressure. HBOT significantly increases the amount of oxygen in the blood, and it is accepted treatment for carbon monoxide poisoning, decompression sickness, air embolism and certain other conditions.

But research to be presented at the meeting this week suggests that hyperbaric oxygen therapy could save millions or even billions of dollars annually in treating victims of stroke, epilepsy and spinal cord injury.

Particularly with respect to treating stroke, "There is potential for a meaningful benefit for patients," said Thom, president of the Undersea and Hyperbaric Medical Society.

The problem is, there's no reason why hyperbaric oxygen therapy should work. "There's a lot of data to say that if a blood vesssel is occluded (blocked), simply providing more oxygen to the blood is not going to help," Thom said. "There's no blood getting through so simply getting more oxygen in the blood is not getting more oxygen to the tissue.

"In fact, there are some theoretical arguements to suggest that giving more oxy
'"/>

Contact: Robert Conn
rconn@wfubmc.edu
336-716-4977
Wake Forest University Baptist Medical Center
11-May-1998


Page: 1 2

Related biology news :

1. Oxygen sensing in worms may hold key to healthy blood pressure in humans
2. Oxygen triggered the evolution of complex life forms
3. Oxygen deficiency is an endocrine disruptor in fish
4. Oxygen key switch in transforming adult stem cells from fat into cartilage
5. Evolution upset: Oxygen-making microbes came last, not first
6. Oxygen is toxic to stem cells
7. Oxygen measurements yield greenhouse clues
8. Tumor Oxygen Level And Blood Flow Fluctuate, Duke Scientists Discover
9. Fake Photosynthesis? Test-Tube System In Science Paper Sheds Light On The Oxygen We Breathe, UD Prof Says
10. Oxygen-Carrying Myoglobin Not Necessary For Survival
11. Stroke Risk Increased In Patients With High Oxygen Use In Brain

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: High pressure Oxygen Therapy Could Offer Widespread Benefits

(Date:12/22/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/fx4bg3/the_global ... "The Global Watermarking and Fingerprinting Markets" report ... http://photos.prnewswire.com/prnh/20130307/600769 This insight provides an ... fingerprinting markets. Watermarking aims to control and monitor ...
(Date:12/19/2014)... VEGAS , Dec. 18, 2014   LaunchKey , ... for the post-password and Internet of Things era, today ... funding. The venture round was led by Metamorphic Ventures ... Rimrock Venture Partners, VegasTechFund, and others.  LaunchKey has raised ...
(Date:12/17/2014)... Research and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ) has ... Market 2015-2019" report to their offering. ... trend upcoming in this market is the increasing demand ... in recording of patient data for quick and correct ...
Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2
(Date:1/22/2015)... (PRWEB) January 22, 2015 Selexis SA, ... mammalian Research Cell Banks (RCBs) used for drug discovery ... Cell Banks will include Next-Generation Sequencing (NGS) ... architecture de-risks biologic manufacturing by ensuring the integrity of ...
(Date:1/22/2015)... , Nueva Jersey , 22 de enero ... for Biomedical Research abre hoy su llamada a nominaciones ... cuya investigación científica ha hecho, o tiene el potencial ... salud humana. Las nominaciones se aceptarán hasta el 15 ...
(Date:1/22/2015)...  Varian Medical Systems (NYSE: VAR ), world leader ... commitment to sustainability with inclusion on a prestigious list of ... healthcare equipment company among the Corporate Knights Global 100 Most ... at Davos, Switzerland . ...
(Date:1/22/2015)... Jan. 22, 2015  Derma Sciences, Inc. (Nasdaq: ... on advanced wound care, announces that AMNIOEXCEL® and ... been added to the Premier, Inc. Regenerative Skin ... for the AMNIOEXCEL® and AMNIOMATRIX® product lines, which ...
Breaking Biology Technology:Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4Varian Honored Among World's 100 Most Sustainable Corporations 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5
Cached News: